Literature DB >> 30056545

Could we avoid computing TMTV of DLBCL patients in routine practice?

Eric Laffon1,2,3,4, Roger Marthan5,6,7.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30056545     DOI： 10.1007/s00259-018-4097-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  7 in total

1.  On the Cutoff of Baseline Total Metabolic Tumor Volume in High-Tumor-Burden Follicular Lymphoma.

Authors:  Eric Laffon; Roger Marthan
Journal:  J Clin Oncol       Date:  2016-12-28       Impact factor: 44.544

2.  Reply to the letter.

Authors:  Hajira Ilyas; N George Mikhaeel; Joel T Dunn; Fareen Rahman; Henrik Møller; Daniel Smith; Sally F Barrington
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09       Impact factor: 9.236

3.  Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?

Authors:  Eric Laffon; Roger Marthan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-17       Impact factor: 9.236

4.  Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma.

Authors:  Nicolas Aide; Charline Lasnon; Gandhi Damaj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-17       Impact factor: 9.236

5.  Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?

Authors:  Anne-Ségolène Cottereau; Irene Buvat; Salim Kanoun; Annibale Versari; Olivier Casasnovas; Stephane Chauvie; Jérôme Clerc; Andrea Gallamini; Michel Meignan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-12       Impact factor: 9.236

6.  Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma.

Authors:  Mathieu Nessim Toledano; P Desbordes; A Banjar; I Gardin; P Vera; P Ruminy; F Jardin; H Tilly; S Becker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-01-17       Impact factor: 9.236

7.  Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma.

Authors:  Hajira Ilyas; N George Mikhaeel; Joel T Dunn; Fareen Rahman; Henrik Møller; Daniel Smith; Sally F Barrington
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-19       Impact factor: 9.236
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.